Myriad Genetics (MYGN) Long-Term Deferred Tax (2010 - 2016)

Myriad Genetics has disclosed Long-Term Deferred Tax across 7 years of filings, most recently posting $12.7 million for Q2 2016.

• In Q2 2016, Long-Term Deferred Tax changed N/A year-over-year to $12.7 million; the TTM figure through Jun 2016 stood at $12.7 million (changed N/A YoY), while the FY2016 annual figure was $12.7 million, changed N/A from the prior year.
• Long-Term Deferred Tax fell to $12.7 million in Q2 2016, from $13.5 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for MYGN reached as high as $30.6 million in Q2 2012 and fell as low as $407000.0 in Q1 2015.
• The 5-year median for Long-Term Deferred Tax is $27.0 million (2012), against an average of $21.3 million.
• Annual changes were most pronounced in 2013 — Long-Term Deferred Tax increased 21.93% — and 2014, when it sank 88.82%.
• A 5-year view of Long-Term Deferred Tax shows it stood at $24.6 million in 2012, then increased by 21.93% to $30.0 million in 2013, then tumbled by 89.33% to $3.2 million in 2014, then jumped by 321.88% to $13.5 million in 2015, then slipped by 5.93% to $12.7 million in 2016.
• According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $12.7 million, $13.5 million, and $407000.0 for Q2 2016, Q4 2015, and Q1 2015 respectively.